BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 16406965)

  • 1. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature.
    Chawla SN; Crispen PL; Hanlon AL; Greenberg RE; Chen DY; Uzzo RG
    J Urol; 2006 Feb; 175(2):425-31. PubMed ID: 16406965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active surveillance for selected patients with renal masses: updated results with long-term follow-up.
    Abou Youssif T; Kassouf W; Steinberg J; Aprikian AG; Laplante MP; Tanguay S
    Cancer; 2007 Sep; 110(5):1010-4. PubMed ID: 17628489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can we avoid surgery in elderly patients with renal masses by using the Charlson comorbidity index?
    O'Connor KM; Davis N; Lennon GM; Quinlan DM; Mulvin DW
    BJU Int; 2009 Jun; 103(11):1492-5. PubMed ID: 19076135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of renal masses followed expectantly.
    Kassouf W; Aprikian AG; Laplante M; Tanguay S
    J Urol; 2004 Jan; 171(1):111-3; discussion 113. PubMed ID: 14665856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed intervention of sporadic renal masses undergoing active surveillance.
    Crispen PL; Viterbo R; Fox EB; Greenberg RE; Chen DY; Uzzo RG
    Cancer; 2008 Mar; 112(5):1051-7. PubMed ID: 18286513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review.
    Kunkle DA; Egleston BL; Uzzo RG
    J Urol; 2008 Apr; 179(4):1227-33; discussion 1233-4. PubMed ID: 18280512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention.
    Kouba E; Smith A; McRackan D; Wallen EM; Pruthi RS
    J Urol; 2007 Feb; 177(2):466-70; discussion 470. PubMed ID: 17222611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active surveillance of renal masses in elderly patients.
    Abouassaly R; Lane BR; Novick AC
    J Urol; 2008 Aug; 180(2):505-8; discussion 508-9. PubMed ID: 18550113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
    Lane BR; Babineau D; Kattan MW; Novick AC; Gill IS; Zhou M; Weight CJ; Campbell SC
    J Urol; 2007 Aug; 178(2):429-34. PubMed ID: 17561141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The growth rate of large renal masses opposes active surveillance.
    Staehler M; Haseke N; Stadler T; Zilinberg E; Nordhaus C; Nuhn P; Khoder WY; Karl A; Stief CG
    BJU Int; 2010 Apr; 105(7):928-31. PubMed ID: 19751265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing renal masses with zero net growth during active surveillance.
    Kunkle DA; Crispen PL; Chen DY; Greenberg RE; Uzzo RG
    J Urol; 2007 Mar; 177(3):849-53; discussion 853-4. PubMed ID: 17296355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small renal masses: current concepts regarding the natural history and reflections on the American Urological Association guidelines.
    Mues AC; Landman J
    Curr Opin Urol; 2010 Mar; 20(2):105-10. PubMed ID: 20075734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth rates of renal cell carcinoma and oncocytoma under surveillance are similar.
    Siu W; Hafez KS; Johnston WK; Wolf JS
    Urol Oncol; 2007; 25(2):115-9. PubMed ID: 17349525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
    Carini M; Minervini A; Lapini A; Masieri L; Serni S
    J Urol; 2006 Jun; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of pathology with tumor size of renal masses.
    Glassman D; Chawla SN; Waldman I; Johannes J; Byrne DS; Trabulsi EJ; Gomella LG
    Can J Urol; 2007 Aug; 14(4):3616-20. PubMed ID: 17784981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
    Klatte T; Patard JJ; de Martino M; Bensalah K; Verhoest G; de la Taille A; Abbou CC; Allhoff EP; Carrieri G; Riggs SB; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Urol; 2008 May; 179(5):1719-26. PubMed ID: 18343437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is surveillance an option for the treatment of small renal masses?
    Van Poppel H; Joniau S
    Eur Urol; 2007 Nov; 52(5):1323-30. PubMed ID: 17669584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal mass biopsy--a renaissance?
    Lane BR; Samplaski MK; Herts BR; Zhou M; Novick AC; Campbell SC
    J Urol; 2008 Jan; 179(1):20-7. PubMed ID: 17997455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history of small renal masses.
    Volpe A; Jewett MA
    Nat Clin Pract Urol; 2005 Aug; 2(8):384-90. PubMed ID: 16474735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of renal tumors in young adults.
    Siemer S; Hack M; Lehmann J; Becker F; Stöckle M
    J Urol; 2006 Apr; 175(4):1240-3; discussion 1243-4. PubMed ID: 16515969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.